Sorry Gekko but I agree with Dazby here . You can’t let the companies funds run to low . OSL needs to do a CR in the coming months on the back of CE approval . It’s not a ideal time I know but to let the company run extremely low on cash is very dangerous . Ideally partnering with a US based company at this point would be a better option and make FDA approval that much easier . A US based company would have more clout when it comes to FDA approval and much bigger / better marketing capacity than OSL could ever hope to have . Maybe one of the Biotecs manufacturing Chemo drugs would be interested ? After all the two work as a package and if good results are achieved could dominate the market
OSL Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)